Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(11): 135-141


Synthesis, anti microbial screening and cytotoxic studies of some novel pyrazole analogs

K. Sony Jacob, Swastika Ganguly.




Abstract

ABSTRACT
Objective: To synthesize novel pyrazole analogs and evaluate their antimicrobial, anthelmintic and cytotoxic activity.
Method: Novel (Z)-1-(4-chlorophenyl)-2-(3,5-dimethyl-4-(substituited phenyldiazenyl)-1H-pyrazol-1-yl)ethanone derivatives were synthesized by conventional method using potassium carbonate in DMF, under reflux condition. The antibacterial study was carried out against gram positive and gram negative bacteria using ciprofloxacin and norfloxacin as standard drugs. Antifungal activity was compared against fluconazole and evaluated using Candida albicans (MTCC 227) and Aspergillus niger (NCIM 1056). Anthelmentic activity assay was carried out on Indian earthworm, Pheretima posthuma. In vitro cytotoxicity studies were also carried out using Dalton’s lymphoma ascites cells (DLA) and Ehrlich ascites carcinoma cells (EAC).
Results: Results of antibacterial study indicated that the compound 22 showed most promising activity against both Gram-positive and Gram-negative organisms. Compound 21 and 24, exhibited relatively good inhibitory profile against Gram negative organism. In case of compounds 25,27-30 exhibited equally potent antifungal activity as that of the standard drug fluconazole. Moreover, compound 21-24,26 showed excellent activity against C. albicans and A.niger. The in vitro cytotoxicity results and anthelmintic reports indicated compound 22 exhibited promising activity among the tested analogs.
Conclusion: These newly synthesized pyrazole analogs, especially 21, 22 and 24 are better scaffolds to develop as broad spectrum chemotherapeutic agents.

Key words: broad spectrum chemotherapeutic agents. Keywords: Pyrazole, anti-bacterial activity, anti-fungal activity, Dalton’s lymphoma ascites cells, Ehrlich ascites carcinoma cells






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.